Cardiac arrest resident survival guide: Difference between revisions
Line 38: | Line 38: | ||
{{familytree/start}} | {{familytree/start}} | ||
{{familytree | | | A01 | | | | | | | | |A01=<div style="float: left; text-align: left | {{familytree | | | A01 | | | | | | | | |A01=<div style="float: left; text-align: left "> '''High Quality CPR:'''<br>'''Compressions:''' | ||
: ❑ Push hard (>2 inches) & fast (>100/min) and allow complete chest recoil | : ❑ Push hard (>2 inches) & fast (>100/min) and <br> allow complete chest recoil | ||
: ❑ Minimize interruptions; rotate compressor every 2 mins | : ❑ Minimize interruptions; rotate compressor every 2 mins | ||
: ❑ If an advanced airway is not in place | : ❑ If an [[advanced airway]] is not in place <br> ventilation:compression ratio should be 30:2 | ||
'''Ventilation:''' | '''Ventilation:''' | ||
: ❑ Avoid excessive ventilation | : ❑ Avoid excessive ventilation | ||
: ❑ Quantitative waveform capnography; If P<sub>ETco<sub>2</sub></sub> < 10mm Hg | : ❑ [[Quantitative waveform capnography]]; If P<sub>ETco<sub>2</sub></sub> < 10mm Hg <br> try to improve CPR quality | ||
: ❑ Intra-arterial pressure; Diastolic pressure < 20 mm Hg | : ❑ Intra-arterial pressure; Diastolic pressure < 20 mm Hg <br> try to improve CPR quality. | ||
---- | ---- | ||
'''Drug Therapy''' <br> ❑ Establish IV/IO access (do not interrupt CPR) <br> ❑ Vasopressor: | '''Drug Therapy:''' <br> ❑ Establish IV/IO access (do not interrupt CPR) <br> ❑ Vasopressor: | ||
:♦ '''[[Epinephrine]]''' '''1 mg IV q3-5 min''' (or 2 mg via ETT) | :♦ '''[[Epinephrine]]''' '''1 mg IV q3-5 min''' (or 2 mg via ETT) | ||
:♦ '''[[Vasopressin]]''' '''40 U''' can replace 2nd or 3rd doses of epinephrine) | :♦ '''[[Vasopressin]]''' '''40 U''' can replace 2nd or 3rd doses of epinephrine) | ||
❑ Antiarrythmic: | ❑ Antiarrythmic: | ||
:♦ '''[[Amiodarone]]''' '''300 mg''' IV bolus + '''150 mg 3-5 min later''' | :♦ '''[[Amiodarone]]''' '''300 mg''' IV bolus + '''150 mg 3-5 min later''' | ||
:♦ '''[[lidocaine]]''' '''1-1.5 mg/Kg IV, max 3mg/Kg''' | :♦ '''[[lidocaine]]''' '''1-1.5 mg/Kg IV, max 3mg/Kg''' | ||
---- | ---- | ||
'''Consider advanced airway:'''<br> | |||
'''Consider advanced airway:'''<br> ❑ Endotracheal intubation or supraglottic advanced airway | : ❑ [[Endotracheal intubation]] or [[supraglottic advanced airway]] | ||
: ❑ Assess : Bilateral chest expansion & breath sounds | |||
: ❑ Check tube placement | |||
: ❑ 8-10 breaths per min with continous compressions | |||
---- | ---- | ||
'''Treat reversible causes:'''<br> | '''Treat reversible causes:'''<br> | ||
❑ [[Hypovolemia]]: Volume ❑ [[Tension Pneumothorax]] | : ❑ [[Hypovolemia]]: Volume ❑ [[Tension Pneumothorax]] | ||
❑ [[Hypoxia]]: Oxygenate ❑ [[cardiac tamponade|Tamponade]]: Pericardiocentesis | : ❑ [[Hypoxia]]: Oxygenate ❑ [[cardiac tamponade|Tamponade]]: [[Pericardiocentesis]] | ||
❑ H+ ions: NaHCo3 ❑ Toxins | : ❑ H+ ions: NaHCo3 ❑ Toxins | ||
❑ Hypo/Hyper K: Replace ❑ Thromb. ([[Pulmonary embolism|PE]]) | : ❑ Hypo/Hyper K: Replace ❑ Thromb. ([[Pulmonary embolism|PE]]) | ||
❑ [[Hypothermia]]: Warm ❑ Thromb. ([[Acute coronary syndrome|ACS]]) | : ❑ [[Hypothermia]]: Warm ❑ Thromb. ([[Acute coronary syndrome|ACS]]) | ||
---- | ---- | ||
'''Shock energy:''' <br> | '''Shock energy:''' <br> | ||
: ❑ Biphasic: 120-200 J based on manufacturers recommendation | : ❑ [[Biphasic]]: 120-200 J based on manufacturers recommendation <br> If unknown use maximum available. Subsequent shocks should be equivalent. | ||
: ❑ Monophasic: 360 J | : ❑ [[Monophasic]]: 360 J | ||
---- | ---- | ||
Return of Spontaneous Circulation (ROSC) | '''Return of Spontaneous Circulation (ROSC):''' <br> | ||
: ❑ Recordable pulse and BP | : ❑ Recordable pulse and BP | ||
: ❑ Sudden sustained increase in P<sub>ETco<sub>2</sub></sub> > 40 mm Hg | : ❑ Sudden sustained increase in P<sub>ETco<sub>2</sub></sub> > 40 mm Hg | ||
: ❑ Sustained arterial pressure waves on intra-arterial monitoring | : ❑ Sustained arterial pressure waves on intra-arterial monitoring |
Revision as of 16:04, 7 January 2014
For cardiac arrest physician extender algorithm click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Rim Halaby; Vidit Bhargava, M.B.B.S [2]
Synonyms and keywords: cardiorespiratory arrest, cardiopulmonary arrest, circulatory arrest
Definition
A cardiac arrest is the abrupt cessation of normal circulation of the blood due to failure of the heart to contract effectively during systole.[1]
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Cardiac arrest is a life-threatening condition and must be treated as such irrespective of the causes.
Common Causes
Reversible Causes
H's
- Hypovolemia
- Hypoxia
- Hydrogen ions (acidosis)
- Hyperkalemia or Hypokalemia
- Hypothermia
- Hypoglycemia or Hyperglycemia
T's
- Tablets or Toxins (tricyclic antidepressants, phenothiazines, beta blockers, calcium channel blockers, cocaine, digoxin, aspirin, acetominophen)
- Cardiac Tamponade
- Tension pneumothorax
- Thrombosis (myocardial infarction)
- Trauma (hypovolemia)
Management
Cardiac Arrest Care
High Quality CPR: Compressions:
Ventilation:
Drug Therapy:
❑ Antiarrythmic:
Consider advanced airway:
Treat reversible causes:
Shock energy:
Return of Spontaneous Circulation (ROSC):
| |||||||||||||||||||||||||||
Adult Cardiac Arrest | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Shout for help ❑ Activate emergency response | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rhythm shockable? | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
VF/VT | Asystole / PEA | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shock | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Box A: ❑ CPR 2 min ❑ Obtain IV/IO access | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rhythm shockable? | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shock | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Box B: | Box C: ❑ CPR 2 min ❑ ObtaimIV/IO access ❑ Administer Epinephrine every 3-5 min ❑ Consider advanced airway and capnography | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rhythm shockable? | No | Rhythm shockable? | Yes | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shock | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Box D: ❑ CPR 2 min ❑ Treat reversible causes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Go back to box A | No | Rhythm shockable? | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shock Then, go to box A or box B | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
If no signs of return of spontaneous circulation: Go to box C or box D If return of spontaneous circulation: Start post cardiac arrest care | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adapted from 2010 AHA guidelines for cardiopulmonary resuscitation and emergency cardiovascular care, part 8.[2]
Acute Immediate Post-Cardiac Arrest Care
Return of spontaneous circulation (ROSC) | |||||||||||||||||||||||||||
Optimize ventilation and oxygenation ❑ Maintain oxygen saturation ≥ 94% ❑ Consider advanced airway and waveform capnography ❑ Do not hyperventilate
| |||||||||||||||||||||||||||
Treat hypotension (SBP<90 mmHg) ❑ IV/IO bolus
❑ Vasopressor infusion
❑ Consider treatable causes ❑ 12-Lead ECG | |||||||||||||||||||||||||||
Follow commands? | |||||||||||||||||||||||||||
No | Yes | ||||||||||||||||||||||||||
❑ Consider induced hypothermia | |||||||||||||||||||||||||||
STEMI Or High suspicion of AMI | |||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||
❑ Coronary reperfusion | |||||||||||||||||||||||||||
Advanced critical care | |||||||||||||||||||||||||||
Adapted from 2010 AHA guidelines for cardiopulmonary resuscitation and emergency cardiovascular care, part 9.[3]
Do's
- Chronotropic drug infusions are recommended as an alternative to pacing in symptomatic and unstable bradycardia.
- Adenosine is recommended as a safe and potentially effective therapy in the initial management of stable undifferentiated regular monomorphic wide-complex tachycardia.
- If using bag and mask ventilation, use adult mask to deliver at least 600 ml of tidal volume, sufficient to produce chest rise, over at least 1 second.
- Perform a head tilt-chin lift maneuver to open the airway, and ensure there is an airtight seal when using bag mask ventilation.
- Oropharyngeal and nasopharyngeal airways may be used to assist in bag and mask ventilation in unconscious patients.
- Continuous waveform capnography is recommended to confirm the placement of endotracehal tube.
- If the cardiac rhythm changes, shift to the appropriate rhythm based strategy.
- If you are not sure of the defibrillator's recommended energy levels, use maximum output level.
Dont's
- Do not use atropine in the management of pulseless electrical activity (PEA)/asystole.
- Do not interrupt the compressions or the use of defibrillator to place an advanced airway, secure IV/IO access or deliver drugs.
- Do not hyperventilate the patient.
- Do not use femoral pulse to assess return of spontaneous circulation (ROSC). The pause in compressions should be used to assess pulse.
References
- ↑ Harrison's Principles of Internal Medicine 16th Edition, The McGraw-Hill Companies, ISBN 0-07-140235-7
- ↑ Neumar RW, Otto CW, Link MS, Kronick SL, Shuster M, Callaway CW; et al. (2010). "Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care". Circulation. 122 (18 Suppl 3): S729–67. doi:10.1161/CIRCULATIONAHA.110.970988. PMID 20956224.
- ↑ Peberdy MA, Callaway CW, Neumar RW, Geocadin RG, Zimmerman JL, Donnino M; et al. (2010). "Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care". Circulation. 122 (18 Suppl 3): S768–86. doi:10.1161/CIRCULATIONAHA.110.971002. PMID 20956225.